STAT Protein Thermal Shift Assays to Monitor Protein-Inhibitor Interactions

被引:4
作者
Iliev, Petar [1 ]
Hanke, Danielle [1 ]
Page, Brent D. G. [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
inhibitors; protein modifications; STAT3; STAT1; thermal shift assays; DIFFERENTIAL SCANNING FLUOROMETRY; SDS-PAGE MIGRATION; SIGNAL TRANSDUCER; TARGETING STAT3; HUMAN BREAST; ACTIVATOR; CYSTEINE; STRATEGIES; KINASE; ROLES;
D O I
10.1002/cbic.202200039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
STAT3 protein is a sought-after drug target as it plays a key role in the progression of cancer. Many STAT3 inhibitors (STAT3i) have been reported, but accumulating evidence suggests many of these act as off-target/indirect inhibitors of STAT signaling. Herein, we describe the STAT protein thermal shift assay (PTSA) as a novel target engagement tool, which we used to test the binding of known STAT3i to STAT3 and STAT1. This revealed STATTIC, BP-1-102, and Cpd188 destabilized both STATs and produced unique migratory patterns on SDS-PAGE gels, suggesting covalent protein modifications. Mass spectrometry experiments confirmed that these compounds are nonspecifically alkylating STATs, as well as an unrelated protein, NUDT5. These experiments have highlighted the benefits of PTSA to investigate interactions with STAT proteins and have helped reveal the novel reactivity of Cpd188. The described PTSA represents a promising chemical biology tool that could be applied to an array of other protein targets.
引用
收藏
页数:10
相关论文
共 42 条
  • [1] Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma
    Adachi, Makoto
    Cui, Caixia
    Dodge, Cristina T.
    Bhayani, Mihir K.
    Lai, Stephen Y.
    [J]. ORAL ONCOLOGY, 2012, 48 (12) : 1220 - 1226
  • [2] Roles of STAT3 defined by tissue-specific gene targeting
    Akira, S
    [J]. ONCOGENE, 2000, 19 (21) : 2607 - 2611
  • [3] Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities
    Ali, Ahmed M.
    Gomez-Biagi, Rodolfo F.
    Rosa, David A.
    Lai, Ping-Shan
    Heaton, William L.
    Park, Ji Sung
    Eiring, Anna M.
    Vellore, Nadeem A.
    de Araujo, Elvin D.
    Ball, Dan P.
    Shouksmith, Andrew E.
    Patel, Ami B.
    Deininger, Michael W.
    O'Hare, Thomas
    Gunning, Patrick T.
    [J]. CHEMMEDCHEM, 2016, 11 (08) : 850 - 861
  • [4] Validating Signal Transducer and Activator of Transcription (STAT) Protein-Inhibitor Interactions Using Biochemical and Cellular Thermal Shift Assays
    Attarha, Sanaz
    Reithmeier, Anja
    Busker, Sander
    Desroses, Matthieu
    Page, Brent D. G.
    [J]. ACS CHEMICAL BIOLOGY, 2020, 15 (07) : 1842 - 1851
  • [5] Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
    Ball, Daniel P.
    Lewis, Andrew M.
    Williams, Declan
    Resetca, Diana
    Wilson, Derek J.
    Gunning, Patrick T.
    [J]. ONCOTARGET, 2016, 7 (15) : 20669 - 20679
  • [6] The application of differential scanning fluorimetry in exploring bisubstrate binding to protein arginine N-methyltransferase 1
    Brown, Jennifer, I
    Page, Brent D. G.
    Frankel, Adam
    [J]. METHODS, 2020, 175 : 10 - 23
  • [7] Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death
    Busker, S.
    Qian, W.
    Haraldsson, M.
    Espinosa, B.
    Johansson, L.
    Attarha, S.
    Kolosenko, I
    Liu, J.
    Dagnell, M.
    Grander, D.
    Arner, E. S. J.
    Tamm, K. Pokrovskaja
    Page, B. D. G.
    [J]. SCIENCE ADVANCES, 2020, 6 (12):
  • [8] Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
    Chen, Kun
    Liu, Juan
    Cao, Xuetao
    [J]. JOURNAL OF AUTOIMMUNITY, 2017, 83 : 1 - 11
  • [9] Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
    Dambacher, Julia
    Beigel, Florian
    Seiderer, Julia
    Haller, Dirk
    Goeke, Burkhard
    Auernhammer, Christoph J.
    Brand, Stephan
    [J]. GUT, 2007, 56 (09) : 1257 - 1265
  • [10] STAT3 differential scanning fluorimetry and differential scanning light scattering assays: Addressing a missing link in the characterization of STAT3 inhibitor interactions
    Desroses, Matthieu
    Busker, Sander
    Astorga-Wells, Juan
    Attarha, Sanaz
    Kolosenko, Iryna
    Zubarev, Roman A.
    Helleday, Thomas
    Grander, Dan
    Page, Brent D. G.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 160 : 80 - 88